Management of Recurrent Weight Gain After Sleeve Gastrectomy: Comparative Effectiveness of Conversion Procedures Versus Obesity Management Medications - Takeaways - MDSpire

Management of Recurrent Weight Gain After Sleeve Gastrectomy: Comparative Effectiveness of Conversion Procedures Versus Obesity Management Medications

  • By

  • Tom Krauze

  • Avner Leshem

  • Yael Sofer

  • Andrei Keidar

  • Shai Meron Eldar

  • Adam Abu-Abeid

  • May 18, 2026

  • 0 min

Share

  • 1

    Sleeve gastrectomy (SG) is the most common bariatric surgery but has a 20-35% rate of recurrent weight gain, leading to potential revisional surgery.

  • 2

    Conversion procedures, primarily Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB), are technically demanding and carry higher risks.

  • 3

    Obesity management medications (OMMs), especially GLP-1 receptor agonists, are gaining traction as alternatives or adjuncts to surgical interventions.

  • 4

    Current expert consensus recommends a stepped-care approach, initiating OMM therapy before considering conversion surgery for recurrent weight gain.

  • 5

    This study aims to compare long-term outcomes of OMM treatment versus conversion surgery following recurrent weight gain after SG.

Original Source(s)

Management of Recurrent Weight Gain After Sleeve Gastrectomy: Comparative Effectiveness of Conversion Procedures Versus Obesity Management Medications

  • by Tom Krauze, Avner Leshem, Yael Sofer, Andrei Keidar, Shai Meron Eldar, Adam Abu-Abeid

  • May 18, 2026

Related Content

Impact of Weight Bias, Stigma and Discrimination on Physical, Mental, and Quality of Life Outcomes of Metabolic and Bariatric Surgery: A Systematic Review

Correction to: One Anastomosis Gastric Bypass Versus Single Anastomosis Sleeve Jejunal Bypass: Does Duodenal Exclusion Matter?

Global Trends and Research Topics in Gastric Bypass Clinical Trials: A Bibliometric Analysis and Latent Dirichlet Allocation (LDA) Study